Abstract
Fibrillar aggregates of amyloid-β (Aβ) are the main component of plaques lining the cerebrovasculature in cerebral amyloid angiopathy. As the predominant Aβ isoform in vascular deposits, Aβ40 is a valuable target in cerebral amyloid angiopathy research. However, the slow process of Aβ40 aggregation in vitro is a bottleneck in the search for Aβ-targeting molecules. In this study, we sought a method to accelerate the aggregation of Aβ40 in vitro, to improve experimental screening procedures. We evaluated the aggregating ability of bicine, a biological buffer, using various in vitro methods. Our data suggest that bicine promotes the aggregation of Aβ40 with high speed and reproducibility, yielding a mixture of aggregates with significant β-sheet-rich fibril formation and toxicity.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Amyloid beta-Peptides / metabolism*
-
Amyloid beta-Peptides / toxicity
-
Animals
-
Cell Line
-
Cell Survival
-
Cerebral Amyloid Angiopathy / pathology*
-
Glycine / analogs & derivatives*
-
Glycine / pharmacology
-
Humans
-
Mice
-
Neurons
-
Peptide Fragments / metabolism*
-
Peptide Fragments / toxicity
-
Protein Aggregates / drug effects*
-
Protein Conformation, beta-Strand / drug effects
Substances
-
Amyloid beta-Peptides
-
Peptide Fragments
-
Protein Aggregates
-
amyloid beta-protein (1-40)
-
N,N-bis(2-hydroxyethyl)glycine
-
Glycine
Grants and funding
This work was supported by National Research Foundation of Korea (NRF-2018R1A6A1A03023718 and NRF-2018R1D1A1B07048857), and POSCO Science Fellowship of POSCO TJ Park Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.